C7ORF29 Polyclonal Antibody, PE-Cy5.5 Conjugated
Applications
Predicted Reactivity
| Overview | |
| Catalog # | bs-15262R-PE-Cy5.5-100uL |
| Product Name | C7ORF29 Polyclonal Antibody, PE-Cy5.5 Conjugated |
| Applications |
WB
|
| Predicted Reactivity | Human |
| Specifications | |
| Conjugation | PE-Cy5.5 |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human C7ORF29 |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1ug/ul |
| Purification | Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target | |
| Gene ID | 113763 |
| Subcellular location | Cytoplasm |
| Synonyms | C7orf29; CG029_HUMAN; Chromosome 7 open reading frame 29; Hypothetical protein LOC113763; Uncharacterized protein C7orf29. |
| Background | Chromosome 7 has been linked to Osteogenesis imperfecta, Pendred syndrome, Lissencephaly, Citrullinemia and Shwachman-Diamond syndrome. The deletion of a portion of the q arm of chromosome 7 is associated with Williams-Beuren syndrome, a condition characterized by mild mental retardation, an unusual comfort and friendliness with strangers and an elfin appearance. Deletions of portions of the q arm of chromosome 7 are also seen in a number of myeloid disorders including cases of acute myelogenous leukemia and myelodysplasia. The C7orf29 gene product has been provisionally designated C7orf29 pending further characterization. |
| Application Dilution | |
| WB | 1:300-5000 |
Frequently asked questions
Which applications is C7ORF29 Polyclonal Antibody, PE-Cy5.5 Conjugated (BS-15262R-PE-CY5-5) validated for, and at what dilution?
BS-15262R-PE-CY5-5 is validated for WB (1:300-5000). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
How should BS-15262R-PE-CY5-5 be stored?
Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. Storage buffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
What immunogen was used to raise C7ORF29 Polyclonal Antibody, PE-Cy5.5 Conjugated (BS-15262R-PE-CY5-5)?
KLH conjugated synthetic peptide derived from human C7ORF29
What are the excitation and emission wavelengths of the PE-Cy5.5 conjugate (BS-15262R-PE-CY5-5)?
PE-Cy5.5 on BS-15262R-PE-CY5-5: excitation / emission 488nm/694nm.